Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Antibody services include competitively priced packages and purification options for antibody production. Service Providers offer support for different types and steps of antibody production—from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification. They also immunize with recombinant proteins or protein fragments provided by the customers(or expressed and purified in labs using cDNAs from the service providers’ extensive in-house genomics library) to generate antibodies in rabbits, chickens, goats, guinea pigs, mice, or rats.
The global Antibody Services market was valued at US$ 2007.6 million in 2023 and is anticipated to reach US$ 3792.8 million by 2030, witnessing a CAGR of 9.4% during the forecast period 2024-2030.
Thermo Fisher ranks the first in terms of revenue share in global market of Antibody Services, occupies 18% of the global market share. While, Covance, with a market share of 14%, comes the second. All the other manufacturers which are not included in the report together consist of approximately 46% of the global market.
North America ranks the top in terms of market size of Antibody Services, which alone consists of 40% of the global market. Europe comes the second, with 31% of the global market. Asia Pacific ranks the third, consists of about 18% of the global antibody service market in the same year. All the other regions combined occupy only 8% of the global Antibody Service market.
This report aims to provide a comprehensive presentation of the global market for Antibody Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Services.
Report Scope
The Antibody Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antibody Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibody Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Segment by Type
Segment by Application
By Region
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibody Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibody Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Monoclonal
1.2.3 Polyclonal
1.2.4 Others
1.3 Market by Application
1.3.1 Global Antibody Services Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 BioScience Companies
1.3.3 BioScience Research Institutions
1.3.4 Hospitals
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antibody Services Market Perspective (2019-2030)
2.2 Antibody Services Growth Trends by Region
2.2.1 Global Antibody Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Antibody Services Historic Market Size by Region (2019-2024)
2.2.3 Antibody Services Forecasted Market Size by Region (2025-2030)
2.3 Antibody Services Market Dynamics
2.3.1 Antibody Services Industry Trends
2.3.2 Antibody Services Market Drivers
2.3.3 Antibody Services Market Challenges
2.3.4 Antibody Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antibody Services Players by Revenue
3.1.1 Global Top Antibody Services Players by Revenue (2019-2024)
3.1.2 Global Antibody Services Revenue Market Share by Players (2019-2024)
3.2 Global Antibody Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antibody Services Revenue
3.4 Global Antibody Services Market Concentration Ratio
3.4.1 Global Antibody Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibody Services Revenue in 2023
3.5 Antibody Services Key Players Head office and Area Served
3.6 Key Players Antibody Services Product Solution and Service
3.7 Date of Enter into Antibody Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibody Services Breakdown Data by Type
4.1 Global Antibody Services Historic Market Size by Type (2019-2024)
4.2 Global Antibody Services Forecasted Market Size by Type (2025-2030)
5 Antibody Services Breakdown Data by Application
5.1 Global Antibody Services Historic Market Size by Application (2019-2024)
5.2 Global Antibody Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Antibody Services Market Size (2019-2030)
6.2 North America Antibody Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Antibody Services Market Size by Country (2019-2024)
6.4 North America Antibody Services Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antibody Services Market Size (2019-2030)
7.2 Europe Antibody Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Antibody Services Market Size by Country (2019-2024)
7.4 Europe Antibody Services Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antibody Services Market Size (2019-2030)
8.2 Asia-Pacific Antibody Services Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Antibody Services Market Size by Region (2019-2024)
8.4 Asia-Pacific Antibody Services Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antibody Services Market Size (2019-2030)
9.2 Latin America Antibody Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Antibody Services Market Size by Country (2019-2024)
9.4 Latin America Antibody Services Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antibody Services Market Size (2019-2030)
10.2 Middle East & Africa Antibody Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Antibody Services Market Size by Country (2019-2024)
10.4 Middle East & Africa Antibody Services Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ThermoFisher
11.1.1 ThermoFisher Company Detail
11.1.2 ThermoFisher Business Overview
11.1.3 ThermoFisher Antibody Services Introduction
11.1.4 ThermoFisher Revenue in Antibody Services Business (2019-2024)
11.1.5 ThermoFisher Recent Development
11.2 GenScript
11.2.1 GenScript Company Detail
11.2.2 GenScript Business Overview
11.2.3 GenScript Antibody Services Introduction
11.2.4 GenScript Revenue in Antibody Services Business (2019-2024)
11.2.5 GenScript Recent Development
11.3 Abcam
11.3.1 Abcam Company Detail
11.3.2 Abcam Business Overview
11.3.3 Abcam Antibody Services Introduction
11.3.4 Abcam Revenue in Antibody Services Business (2019-2024)
11.3.5 Abcam Recent Development
11.4 MBS
11.4.1 MBS Company Detail
11.4.2 MBS Business Overview
11.4.3 MBS Antibody Services Introduction
11.4.4 MBS Revenue in Antibody Services Business (2019-2024)
11.4.5 MBS Recent Development
11.5 ROCKLAND
11.5.1 ROCKLAND Company Detail
11.5.2 ROCKLAND Business Overview
11.5.3 ROCKLAND Antibody Services Introduction
11.5.4 ROCKLAND Revenue in Antibody Services Business (2019-2024)
11.5.5 ROCKLAND Recent Development
11.6 ProSci
11.6.1 ProSci Company Detail
11.6.2 ProSci Business Overview
11.6.3 ProSci Antibody Services Introduction
11.6.4 ProSci Revenue in Antibody Services Business (2019-2024)
11.6.5 ProSci Recent Development
11.7 Anaspec
11.7.1 Anaspec Company Detail
11.7.2 Anaspec Business Overview
11.7.3 Anaspec Antibody Services Introduction
11.7.4 Anaspec Revenue in Antibody Services Business (2019-2024)
11.7.5 Anaspec Recent Development
11.8 Bio-Rad
11.8.1 Bio-Rad Company Detail
11.8.2 Bio-Rad Business Overview
11.8.3 Bio-Rad Antibody Services Introduction
11.8.4 Bio-Rad Revenue in Antibody Services Business (2019-2024)
11.8.5 Bio-Rad Recent Development
11.9 Covance
11.9.1 Covance Company Detail
11.9.2 Covance Business Overview
11.9.3 Covance Antibody Services Introduction
11.9.4 Covance Revenue in Antibody Services Business (2019-2024)
11.9.5 Covance Recent Development
11.10 Capra Science
11.10.1 Capra Science Company Detail
11.10.2 Capra Science Business Overview
11.10.3 Capra Science Antibody Services Introduction
11.10.4 Capra Science Revenue in Antibody Services Business (2019-2024)
11.10.5 Capra Science Recent Development
11.11 Innovagen
11.11.1 Innovagen Company Detail
11.11.2 Innovagen Business Overview
11.11.3 Innovagen Antibody Services Introduction
11.11.4 Innovagen Revenue in Antibody Services Business (2019-2024)
11.11.5 Innovagen Recent Development
11.12 APS
11.12.1 APS Company Detail
11.12.2 APS Business Overview
11.12.3 APS Antibody Services Introduction
11.12.4 APS Revenue in Antibody Services Business (2019-2024)
11.12.5 APS Recent Development
11.13 Randox
11.13.1 Randox Company Detail
11.13.2 Randox Business Overview
11.13.3 Randox Antibody Services Introduction
11.13.4 Randox Revenue in Antibody Services Business (2019-2024)
11.13.5 Randox Recent Development
11.14 GL Biochem
11.14.1 GL Biochem Company Detail
11.14.2 GL Biochem Business Overview
11.14.3 GL Biochem Antibody Services Introduction
11.14.4 GL Biochem Revenue in Antibody Services Business (2019-2024)
11.14.5 GL Biochem Recent Development
11.15 Abgent
11.15.1 Abgent Company Detail
11.15.2 Abgent Business Overview
11.15.3 Abgent Antibody Services Introduction
11.15.4 Abgent Revenue in Antibody Services Business (2019-2024)
11.15.5 Abgent Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research